Ohad Cohen

Title: Ohad Cohen: Innovator in Diabetes Management

Introduction

Ohad Cohen is a notable inventor based in Kiryat Uno, Israel. He has made significant contributions to the field of diabetes management through his innovative patents. With a total of two patents to his name, Cohen's work focuses on improving the lives of individuals with diabetes by addressing critical issues related to insulin delivery and hypoglycemia.

Latest Patents

Cohen's latest patents include techniques for the management of insufficient hypoglycemia response. These techniques involve obtaining the amount of insulin remaining in a patient's body and determining the quantity of insulin needed within a future time period. The methods also identify conditions where a patient's glucose level may continue to decrease despite the suspension of basal insulin dosage delivery. Additionally, his patent on methods and apparatus for detecting and reacting to insufficient hypoglycemia response provides a method for delivering blood glucose data. This method identifies conditions indicating ongoing hypoglycemia when basal insulin delivery is suspended and performs necessary actions to mitigate the risk.

Career Highlights

Ohad Cohen is currently employed at Medtronic Minimed, Inc., a leading company in diabetes management technology. His work at Medtronic has allowed him to develop and refine his innovative techniques, contributing to advancements in insulin delivery systems.

Collaborations

Cohen collaborates with talented professionals in his field, including Di Wu and Rebecca K Gottlieb. These collaborations enhance the development of effective solutions for diabetes management.

Conclusion

Ohad Cohen's contributions to diabetes management through his innovative patents demonstrate his commitment to improving patient care. His work continues to influence the field and offers hope for better management of diabetes in the future.